STATE PHARMACEUTICALS CORPORATION OF SRI LANKA Tenders

Ranitidine Injection BP/USP, 50mg/2ml Each 2ml ampoule to contain Ranitidine Hydrochloride BP/USP equivalent to 50mg of Ranitidine in Water for Injection BP/USP

Dehydrated Alcohol(Ethanol)Injection USP 5ml ampoule Each ampoule to contain not less than 95% to 98% by volume of ethanol USP for intravenous use.

Pralidoxime Chloride for Injection USP 1g in 20mL Ampoule Each 20mL ampoule to contain 1g of sterile Pralidoxime Chloride USP for reconstitution with water for injection BP/USP suitable for subcutaneous, intramuscular and intravenous injection.

Ceftriaxone for injection BP/USP 1g Each vial to contain sterile Ceftriaxone Sodium BP/USP equivalent to 1g of Ceftriaxone as sterile dry powder for reconstitution with water for injection BP/USP for intravenous injection

Cefuroxime Sodium for Injection BP, 750mg

Cefotaxime for Injection USP 1g. Each 1g vial to contain sterile Cefotaxime Sodium BP/USP equivalent to 1g of Cefotaxime as sterile dry powder for reconstitution with Water for Injection BP/USP for intramuscular and intravenous use.

Fentanyl Citrate Transdermal Self adhesive patches 50 microgram/h, 20cm x 20cm

Fentanyl Citrate Transdermal self adhesive patches 25 microgram/h Fentanyl Citrate transdermal self-adhesive patches 25mcg/h Each self-adhesive transdermal patch to contain Fentanyl Citrate in a suitable matrix or reservoir presentation. The content

Morphine Tablet 10mg 1,080,000 Tablets 540,000 Tablets/January 2026 Morphine Tablet BP 10mg. Each Tablet to contain 10mg of Morphine Sulphate BP. 540,000 Tablets/May 2026 1 2 Note: 01. The shelf life of the product should be minimum of 24 months Pack

Morphine sulphate Controlled Release Tablets 10mg. Each tablet to contain 10mg of Morphine Sulphate BP/USP in a suitable controlled release form.